SG Americas Securities LLC raised its stake in shares of Humana Inc. (NYSE:HUM) by 118.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,888 shares of the insurance provider’s stock after purchasing an additional 2,649 shares during the period. SG Americas Securities LLC’s holdings in Humana were worth $2,023,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in HUM. Cerebellum GP LLC bought a new position in Humana during the 2nd quarter worth $26,000. American Research & Management Co. bought a new position in Humana during the 3rd quarter worth $29,000. Tortoise Investment Management LLC bought a new position in Humana during the 3rd quarter worth $31,000. Prospera Financial Services Inc bought a new position in Humana during the 3rd quarter worth $39,000. Finally, Jaffetilchin Investment Partners LLC bought a new position in Humana during the 2nd quarter worth $52,000. 92.43% of the stock is owned by institutional investors and hedge funds.
A number of brokerages have weighed in on HUM. Truist increased their price target on Humana from $455.00 to $475.00 in a report on Tuesday, October 13th. JPMorgan Chase & Co. lifted their price target on Humana from $394.00 to $452.00 and gave the company an “overweight” rating in a research note on Tuesday, August 18th. Credit Suisse Group lifted their price target on Humana from $423.00 to $465.00 and gave the company an “outperform” rating in a research note on Wednesday, November 4th. Smith Barney Citigroup lifted their price target on Humana from $469.00 to $496.00 in a research note on Wednesday, November 4th. Finally, Sanford C. Bernstein began coverage on Humana in a research note on Thursday, October 1st. They set a “market perform” rating and a $459.00 price target for the company. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Humana has a consensus rating of “Buy” and a consensus price target of $447.35.
HUM stock opened at $406.21 on Friday. The firm has a market capitalization of $53.76 billion, a PE ratio of 13.02, a PEG ratio of 1.96 and a beta of 0.94. The company has a quick ratio of 1.69, a current ratio of 1.81 and a debt-to-equity ratio of 0.38. The stock has a 50-day simple moving average of $426.69 and a two-hundred day simple moving average of $404.01. Humana Inc. has a twelve month low of $208.25 and a twelve month high of $474.70.
Humana (NYSE:HUM) last issued its quarterly earnings results on Tuesday, November 3rd. The insurance provider reported $3.08 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.81 by $0.27. The firm had revenue of $20.08 billion during the quarter, compared to the consensus estimate of $18.59 billion. Humana had a return on equity of 22.74% and a net margin of 5.58%. The company’s revenue for the quarter was up 23.6% on a year-over-year basis. During the same quarter last year, the company posted $5.03 EPS. On average, equities research analysts anticipate that Humana Inc. will post 18.74 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be given a $0.625 dividend. The ex-dividend date of this dividend is Wednesday, December 30th. This represents a $2.50 dividend on an annualized basis and a yield of 0.62%. Humana’s payout ratio is 13.99%.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Recommended Story: Example of operating income, EBIT and EBITDA
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.